自杀意念
食品药品监督管理局
重性抑郁障碍
医学
萧条(经济学)
药品
精神科
药理学
毒物控制
急诊医学
自杀预防
宏观经济学
经济
认知
摘要
The Food and Drug Administration (FDA) announced Aug. 3 approval of Janssen Pharmaceutical's supplemental new drug application (sNDA) for the expanded use of SPRAVATO esketamine Clll nasal spray for the treatment of major depressive disorder (MDD) with acute suicidal ideation or behavior. SPRAVATO was initially approved by the FDA March 5, 2019, for the treatment of treatment‐resistant depression.
科研通智能强力驱动
Strongly Powered by AbleSci AI